Improving patient journeys in food allergy
Register your interest for our interactive CME (EACCME-accredited), held at EAACI 2022, for improving the patient experience at each stage of their food allergy journey.
- Explore diagnostic approaches, novel therapeutic strategies and tips for food allergy prevention in high-risk individuals
- Expert faculty: Professor Alexandra Santos, Professor Montserrat Fernández-Rivas and Professor Gideon Lack
- Patient case studies
By clicking the “Register your interest” button you confirm you are happy to receive further information about this CME and related Medthority updates.
Through completion of the CME, you will gain 1 CME-CPD point through EACCME.
Developed from a live symposium, the CME will explore approaches for the diagnosis, treatment and prevention of food allergy, with insights into emerging approaches to improve management. Learn about diagnostic strategies which may help to improve the patient’s experience, and how novel therapeutic strategies for food allergy could help ease some of the anxiety associated with strict avoidance diets. Discover more about food allergy prevention, and how this can benefit high-risk individuals. Step through patient case studies which focus on food allergy management and prevention.
Professor Alexandra Santos
Professor Alexandra Santos is Professor of Paediatric Allergy at King’s College London and Honorary Consultant in Paediatric Allergy at the Evelina London Children’s Hospital in London, UK. The Santos Lab aims to improve the accuracy and safety of food allergy diagnosis and our understanding of the mechanisms of food allergy and oral tolerance in IgE-sensitised children to identify new targets for definitive treatment of food allergy.
Professor Santos has received multiple prestigious awards from the Medical Research Council (MRC) and additional funding from the NIH, Food Allergy Research and Education (FARE), the Welcome Trust, the European Commission, Asthma UK as Principal Investigator of Asthma UK Centre in Allergic Mechanisms of Asthma. She is the Chair of the Board of the Food Allergy Interest Group of European Academy of Allergy and Clinical Immunology (EAACI) and of the upcoming EAACI Food Allergy Guidelines.
Disclosures: Professor Santos has grants from Medical Research Council (MR/M008517/1; MC/PC/18052; MR/T032081/1), Food Allergy Research and Education (FARE), the NIH, Asthma UK (AUK-BC-2015-01), Immune Tolerance Network/National Institute of Allergy and Infectious Diseases (NIAID, NIH), the European Commission and the Wellcome Trust; consultancy and/or speaker fees from Thermo Scientific, Nutricia, Infomed, Novartis, Allergy Therapeutics, Buhlmann, as well as research support from Buhlmann and Thermo Fisher Scientific through a collaboration agreement with King's College London.
Professor Gideon Lack
Professor Gideon Lack is Professor of Paediatric Allergy at King’s College London and Head of the Children’s Allergy Clinical Academic Group at King’s Health Partners Institute of Women and Children’s Health at Evelina London, Guy’s & St. Thomas’ NHS Foundation Trust.
He was co-author on the LEAP (Learning Early About Peanut allergy) study that showed that early consumption of peanuts in atopic infants reduces the development of peanut allergy by >80%, which translated to changes to health policy in the USA and Australia. His research focuses on the prevalence of food allergies in children and the relationship between food allergies, eczema, and asthma. He works on novel immune-modulatory treatments for food allergies and on developing new strategies to prevent the development of allergies and asthma in children and adults.
Disclosures: Professor Lack is a stock shareholder in DBV Technologies, Mission Mighty Me, and serves as a Member of Scientific Advisory Board at DBV Technologies S.A. He received an honoraria from EPG Health for participating in a company-sponsored speaker’s bureau.
Professor Montserrat Fernández-Rivas
Dr Montserrat Fernández-Rivas is Head of the Allergy Department at the Hospital Clínico San Carlos in Madrid, and Associate Professor of Medicine at the Universidad Complutense de Madrid. She is also Head of the Allergy research group at the IdISSC (Instituto de Investigación Sanitaria San Carlos).
Professor Fernández-Rivas is active in research into food allergy, specifically in food allergens, diagnosis, epidemiology, severity, food safety and immunotherapy of food allergy. She was a recipient of the 2019 EAACI Clemens von Pirquet award for clinical research, and was principal investigator in food allergy research projects funded by the Spanish Government, in the Spanish research Networks ARADyAL (2016-2021) and Vegetalia, in several integrated projects funded by the European Commission under 6th and 7th Framework Programs (SAFE, CREATE, EuroPrevall, FAST, iFAAM), and in clinical trials of oral immunotherapy and biologicals for food allergy.
Disclosures: Professor Fernández-Rivas received grants/research support to her institution from ISC III and Aimmune; and received honoraria or consultation fees from Aimmune, ALK, Diater, Ga2LEN, HAL Allergy, GlaxoSmithKline, Medscape, Novartis, Reacta Healthcare, SPRIM and DBV.
If you want to learn more, explore our Food Allergy Learning Zone, where you can learn about the prevalence of food allergies, the pathophysiology of IgE-mediated food allergy, key aspects of diagnosis, current management strategies and new developments on the horizon.
Live accredited symposium
1st July 12:00-13:00 CEST
Improving patient journeys in food allergy
This live Symposium will explore approaches for the diagnosis, treatment and prevention of food allergy, with insights into emerging approaches to improve management.
Through attending this Symposium, you will gain 1 CME-CPD point through EACCME.
This content has been developed independently of the sponsor, Novartis Pharma AG, which has had no editorial input into the content. Medthority received education funding from the sponsor in order to provide healthcare professionals (as defined by Czech Republic Law and regulations) registered for the EAACI Hybrid Congress, and following the congress to Medthority’s healthcare professional members, access to the highest quality medical and scientific information, education and associated relevant content.